Seeking Alpha

Seeking Alpha Portfolio App for iPad

1,357 people get EXAS articles and Market Currents by email alert.

Get email alerts on EXAS »

EXAS

EXACT Sciences Corporation

5/23/2013, 3:19 AM ET

Quote & Headlines Market Currents StockTalk

exas chart

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

1,357 people get EXAS articles and Market Currents by email alert.

Get email alerts on EXAS »

HEADLINES:

ALL | PRO | FOCUS | RELATED | TRANSCRIPTS | NEWS & PR

6 Ways You Can Profit From Molecular Diagnostics
Cory Renauer • Wed, May 22 • 8 Comments
Exact Sciences Corporation Presents at UBS Global Healthcare Conference, May-21-2013 10:30 AM
Tue, May 21
A Game-Changing Cancer Screen For Exact Sciences
Biotech Vet • Tue, May 21 • 6 Comments
Cramer's Mad Money - The Kids Love Tesla (5/20/13)
SA Editor Miriam Metzinger • Tue, May 21 • 1 Comment
Exact Sciences to Participate in May Investor Conferences

Business Wire (May 3, 2013)
Exact Sciences Management Discusses Q1 2013 Results - Earnings Call Transcript
Wed, May 1
Exact Sciences to Host First-Quarter 2013 Results Webcast and Call

Business Wire (Apr 26, 2013)
Exact Sciences' Cancer Test Won't Be A Commercial Success
PropThink • Fri, Apr 19 • 52 Comments
Exact Sciences' CEO Discusses Preliminary Top Line Results of DeeP-C Pivotal Clinical Trial (Transcript)
Thu, Apr 18
Top-Line Data Show Exact Sciences’ Cologuard Test Demonstrates 92 Percent Sensitivity in the Detection of Colorectal Cancer

Business Wire (Apr 18, 2013)
Exact Sciences Schedules Announcement and Call for Top-Line Results of DeeP-C Clinical Trial

Business Wire (Apr 17, 2013)
Exact Sciences: A Cancer Diagnostic Play With An Upcoming Catalyst This Month
Healthcare Specialist • Mon, Apr 8 • 11 Comments
Cramer's Mad Money - 13 Things To Watch In The Week Ahead (4/5/13)
SA Editor Miriam Metzinger • Sun, Apr 7 • 3 Comments
Exact Sciences to Participate in 25th Annual Roth Conference

Business Wire (Mar 11, 2013)
EXACT Sciences' CEO Presents at Citi Global Healthcare Conference (Transcript)
Tue, Feb 26 • 2 Comments
Exact Sciences Management Discusses Q4 2012 Results - Earnings Call Transcript
Wed, Feb 20
Exact Sciences Reports Fourth-Quarter 2012 Financial Results

Business Wire (Feb 20, 2013)
Exact Sciences Submits Second Module of Premarket Approval Application to FDA

Business Wire (Feb 18, 2013)
Exact Sciences to Host Fourth-Quarter, Full-Year 2012 Results Webcast and Call

Business Wire (Feb 12, 2013)
Exact Sciences to Participate in February Investor Conferences

Business Wire (Feb 12, 2013)

To learn more about Seeking Alpha Pro, click here.

A Game-Changing Cancer Screen For Exact Sciences
Biotech Vet • Tue, May 21 • 6 Comments
Exact Sciences' Cancer Test Won't Be A Commercial Success
PropThink • Fri, Apr 19 • 52 Comments
Exact Sciences: A Cancer Diagnostic Play With An Upcoming Catalyst This Month
Healthcare Specialist • Mon, Apr 8 • 11 Comments
Epigenomics AG Vs. Exact Sciences: Who Wins The CRC Early Detection Fight?
Gilbert Gerber • Wed, Jan 16 • 37 Comments
For Exact Sciences, Approval May Be The Easy Part
Stephen Simpson • Thu, Aug 23, 2012 • 13 Comments
EXACT Sciences: Pivotal Colon Cancer Screening Test Results Expected Later This Year
Mike Havrilla • Tue, Jun 12, 2012 • 3 Comments
Exact Sciences Could Be Exactly What Biotech Investors Need
Stephen Simpson • Mon, Mar 5, 2012 • 18 Comments
Exact Sciences Setting The Standard For Early Cancer Detection
VFC's Stock House • Thu, Nov 17, 2011 • 9 Comments
Detecting More Upside Potential for EXACT Sciences
Mike Havrilla • Fri, Oct 22, 2010 • 15 Comments
EXACT Sciences: Buy and Hold for Long-Term Upside
Mike Havrilla • Sun, Nov 8, 2009 • 5 Comments
EXACT Sciences: Patience Required for Long-Term Upside
Mike Havrilla • Wed, Nov 4, 2009 • 1 Comment
EXACT Sciences: 8 Points Following Q2 Earnings
Mike Havrilla • Sun, Aug 16, 2009
EXACT Sciences' Key to Future Earnings
Mike Havrilla • Sun, Aug 2, 2009 • 2 Comments
EXACT Sciences Shows Strong Breakout
Microcap Speculator • Sun, May 3, 2009 • 1 Comment
A New Strategy for EXACT Sciences
Mike Havrilla • Sun, Jul 6, 2008 • 4 Comments
Exact Sciences 'Surprised' By FDA Warning Letter
10Q Detective • Tue, Nov 6, 2007
EXACT Sciences Corporation: Train Wreck or About to Leave the Station?
Mike Havrilla • Mon, Oct 29, 2007 • 1 Comment
Detecting Big Upside for EXACT Sciences Corporation
Mike Havrilla • Mon, Oct 8, 2007

6 Ways You Can Profit From Molecular Diagnostics
Cory Renauer • Wed, May 22 • 8 Comments
Cramer's Mad Money - The Kids Love Tesla (5/20/13)
SA Editor Miriam Metzinger • Tue, May 21 • 1 Comment
Cramer's Mad Money - 13 Things To Watch In The Week Ahead (4/5/13)
SA Editor Miriam Metzinger • Sun, Apr 7 • 3 Comments
Response Genetics' Competitors: Who To Watch, Who To Worry About
Bay Area Biotech • Fri, Feb 8 • 7 Comments
Biopharma Catalyst Trades To Watch For This Week
Scott Matusow • Mon, Jan 28 • 23 Comments
First Half Of 2013 To Be A Critical Time For Exact Sciences
Josh Hutheson • Wed, Jan 9 • 1 Comment
Cramer's Mad Money - Which Sectors Will Make A Comeback In 2013? (1/7/13)
SA Editor Miriam Metzinger • Tue, Jan 8 • 1 Comment
Cramer's Lightning Round - Tronox Is All About A Lawsuit (12/20/12)
SA Editor Miriam Metzinger • Fri, Dec 21, 2012 • 6 Comments
9 High-Growth Healthcare Stocks With Bearish Stock Trends
Kapitall • Wed, Dec 19, 2012 • 4 Comments
2 Biotech Stocks I'm Considering Today
Matt Schilling • Wed, Dec 12, 2012 • 3 Comments
Testing, Testing: Analyst Kevin DeGeeter On 5 Good Bets In Cancer Diagnostics
Life Sciences Report • Fri, Nov 30, 2012 • 1 Comment
Hedge Funds Are Buying These 6 High-Growth Biotech Stocks
Kapitall • Thu, Nov 22, 2012 • 6 Comments
5 Healthcare Companies With Insider Buying During November 2012
Markus Aarnio • Mon, Nov 5, 2012 • 2 Comments
7 Low-Debt Small Cap Healthcare Stocks Positioned For Growth
ZetaKap • Tue, Aug 21, 2012 • 1 Comment
DWAS: New Technical Small Cap ETF Follows Relative Strength
Ron Rowland • Wed, Aug 1, 2012
7 Fast Growing Small Cap Biotech Stocks With Analyst Confidence
ZetaKap • Fri, Jul 6, 2012
Top 10 Stocks Performance And Second Half Expectations
Chris Katje • Thu, Jul 5, 2012 • 8 Comments
Trovagene: The 1 Stock That Could've Saved Steve Jobs' Life
James Altucher • Mon, Jun 18, 2012 • 55 Comments
9 Rallying Biotech Stocks Being Snapped Up By Hedge Funds
Kapitall • Tue, May 15, 2012
9 High-Growth Biotech Stocks Being Bought Up By Hedge Funds
Kapitall • Wed, Apr 11, 2012

Exact Sciences Corporation Presents at UBS Global Healthcare Conference, May-21-2013 10:30 AM
Tue, May 21
Exact Sciences Management Discusses Q1 2013 Results - Earnings Call Transcript
Wed, May 1
Exact Sciences' CEO Discusses Preliminary Top Line Results of DeeP-C Pivotal Clinical Trial (Transcript)
Thu, Apr 18
EXACT Sciences' CEO Presents at Citi Global Healthcare Conference (Transcript)
Tue, Feb 26 • 2 Comments
Exact Sciences Management Discusses Q4 2012 Results - Earnings Call Transcript
Wed, Feb 20
Exact Sciences Management Discusses Q3 2012 Results - Earnings Call Transcript
Tue, Oct 30, 2012
Exact Sciences Management Discusses Q2 2012 Results - Earnings Call Transcript
Wed, Jul 25, 2012 • 1 Comment
EXACT Sciences Corp. Q2 2008 Earnings Call Transcript
Fri, Aug 8, 2008
EXACT Sciences Corporation Q4 2007 Earnings Call Transcript
Tue, Mar 18, 2008
EXACT Sciences Corporation Q4 2007 Earnings Call Transcript
Wed, Feb 6, 2008

Exact Sciences to Participate in May Investor Conferences

Business Wire (May 3, 2013)
Exact Sciences to Host First-Quarter 2013 Results Webcast and Call

Business Wire (Apr 26, 2013)
Top-Line Data Show Exact Sciences’ Cologuard Test Demonstrates 92 Percent Sensitivity in the Detection of Colorectal Cancer

Business Wire (Apr 18, 2013)
Exact Sciences Schedules Announcement and Call for Top-Line Results of DeeP-C Clinical Trial

Business Wire (Apr 17, 2013)
Cramer: Major Profit Potential in 2 Diagnostics

at CNBC.com (Apr 5, 2013)
Exact Sciences to Participate in 25th Annual Roth Conference

Business Wire (Mar 11, 2013)
Exact Sciences Reports Fourth-Quarter 2012 Financial Results

Business Wire (Feb 20, 2013)
Exact Sciences Submits Second Module of Premarket Approval Application to FDA

Business Wire (Feb 18, 2013)
Exact Sciences to Host Fourth-Quarter, Full-Year 2012 Results Webcast and Call

Business Wire (Feb 12, 2013)
Exact Sciences to Participate in February Investor Conferences

Business Wire (Feb 12, 2013)
Cramer: There's One Word for This Stock - Poop!

at CNBC.com (Jan 7, 2013)
Exact Sciences to Participate in J.P. Morgan Healthcare Conference

Business Wire (Jan 3, 2013)
Lightning Round: LyondellBasell, NXP Semiconductors and More

at CNBC.com (Dec 20, 2012)
Exact Sciences Submits First Module of Premarket Approval Application to FDA

Business Wire (Dec 10, 2012)
Exact Sciences to participate in Canaccord Genuity Medical Technology & Diagnostics Forum

Business Wire (Nov 29, 2012)
Exact Sciences Completes Enrollment of DeeP-C Clinical Trial for Colorectal Cancer Screening

Business Wire (Nov 15, 2012)
Exact Sciences to Participate in November Investor Conferences

Business Wire (Nov 7, 2012)
Exact Sciences Reports Third-Quarter 2012 Financial Results

Business Wire (Oct 30, 2012)
Exact Sciences’ Scientific Poster Presented at American Association for Cancer Research Meeting

Business Wire (Oct 18, 2012)
Exact Sciences to Host Third-Quarter 2012 Results Webcast and Call

Business Wire (Oct 17, 2012)

EXAS vs. ETF Alternatives

Company Description

Currently, there's no company description for EXAS.

Sector: Healthcare

Industry: Biotechnology

Country: United States

Red Acre Investments
Binary Event Watch April 2013 - Part II http://bit.ly/114CVMl ... $RPTP $AVEO $DCTH $VVUS $SRPT $PFE $DRRX $PTIE $TTNP $XNPT $EXAS
Apr 12, 12:25 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Red Acre Investments
April binary event watch pt2 $PFE $RPTP $TTNP $AVEO $DCTH $PFE $SRPT $VVUS $AGN $DRRX $PTIE $XNPT $EXAS get it free: http://bit.ly/10SbDco
Apr 11, 7:03 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

dusteater
$SRPT $EXAS
Apr 1, 4:58 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
7 Low-Debt Small Cap Healthcare Stocks Positioned For Growth http://bit.ly/QXzJu7 $ABAX $EXAS $GIVN $LMNX $OSUR $SPNC $TSRO @ZetaKap
8/21/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
7 Fast Growing Small Cap Biotech Stocks With Analyst Confidence http://bit.ly/Odu3LZ $EXAS $MACK $NKTR $THLD $CADX $SNTS $ACOR @ZetaKap
7/6/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

tradingblues1
Will have my eye on INVN, IDIX, ATLS, and EXAS this week. Check out the Charts http://bit.ly/xqYBPW
3/11/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Jim Van Meerten
EXAS - 60% Barchart technical sell signal - 20.74% off its recent high - Relative Strength Index 36.35% and falling
8/4/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Jim Van Meerten
EXAS - 96% Barchart technical buy signal - 17 new highs and up 20.58% in the last month with a Relative strength Index of 72.57% and rising
7/5/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

candlestickpicks
$EXAS completed a Bullish Engulfing candlestick pattern on 04/12/2011. Look for an upward price movement on 04/13/2011
4/13/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Jim Van Meerten
EXAS - 88% Barchart technical buy signal-16 new highs and up 37.74% last month-Relative Strength Index 81.71% and rising
4/2/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES